ITMCTR2100005097
Not yet recruiting
未知
A Prospective and Randomized Controlled Trial of Empirical Formula of Traditinal Chinease Medicine in Treating Chronic Heart Failure
Chinese Academy of Medical Sciences Fuwai Hospital0 sitesTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Chinese Academy of Medical Sciences Fuwai Hospital
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18 to 75 years;
- •2\. Patients who meet the diagnostic criteria of Western medicine for coronary heart disease, elective patients within two weeks after DCB surgery;
- •3\. Voluntary selection of patients who undergo coronary angiography 12 months after surgery;
- •4\. Meet the TCM criteria for syndrome differentiation of Qi deficiency and blood stasis (total score \>\=8 points, and secondary symptoms \>\= 4 points);
- •5\. The subjects voluntarily participated in the trial and signed the informed consent.
Exclusion Criteria
- •1\. Heart valve disease, congenital heart disease, aortic dissection or aortic aneurysm requiring surgical or interventional treatment;
- •2\. Hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy, active myocarditis, infective endocarditis, constrictive pericarditis or other pericardial diseases;
- •3\. Patients with malignant arrhythmia and poorly controlled hypertension;
- •4\. Cardiac synchronization therapy within 3 months; cardiac PCI, CABG and other major vascular surgery or acute coronary syndrome within 1 month;
- •5\. Cerebrovascular events such as old stroke and transient cerebral ischemia occurred within 6 months;
- •6\. Patients with serious primary diseases and dysfunctions of the lung, liver, kidney, hematopoietic system, immune system, etc.;
- •7\. Subjects who participated in other drug clinical trials or interventional studies within the first four weeks of this trial;
- •8\. Patients with serious primary diseases and dysfunctions of the lung, liver, kidney, hematopoietic system, immune system, etc.;
- •9\. Subjects who participated in other drug clinical trials or interventional studies within the first four weeks of this trial;
- •10\. Those who are deemed unsuitable to participate in clinical trials by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
efficacy of omeprazole for prevention of esophageal stricture in grade 2b and 3a corrosive esophageal injuriesesophageal strictureomeprazolecorrosive esophagitisTCTR20190504001Faculty of medicine20
Recruiting
Not Applicable
Vitamin D supplementation in PregnancyCTRI/2014/06/004670Indian Council of Medical Research ICMR368
Active, not recruiting
Phase 1
A Randomised Controlled Trial to Investigate the effectiveness of the Healthy Sexual Functioning (HSF) Module and Selective Serotonin Reuptake Inhibitor (SSRI) Medication to treat Deviant Sexual Arousal as part of the HM Prison Sex Offender Treatment Programme. - HSF-SSRI TrialDeviant Sexual Arousal (sex offender)MedDRA version: 8.1Level: LLTClassification code 10063494Term: Sexual offenceEUCTR2005-003435-40-GBDepartment of Health240
Recruiting
Not Applicable
IMPROVE- Improving Maternal and Progency Obesity Via Exercise: Antenatal exercise in overweight and obese women and its effects on offspring and maternal healthObesity preventionReproductive Health and Childbirth - Fetal medicine and complications of pregnancyMetabolic and Endocrine - Other metabolic disordersDiet and Nutrition - ObesityACTRN12612000932864iggins Institute, University of Auckland100
Not yet recruiting
Not Applicable
Distant Vision improvement with Ayurvedic medicine Vishamajwarantak lauha in simple myopiaHealth Condition 1: PCS-CTRI/2021/11/038027Dr Rutuja Bhalekar